share_log
Breakings ·  Nov 7 19:30
Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment